24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Brucellosis: epidemiology, pathogenesis, diagnosis and treatment–a comprehensive review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Brucellosis is a pervasive zoonotic disease caused by various Brucella species. It mainly affects livestock and wildlife and poses significant public health threats, especially in regions with suboptimal hygiene, food safety, and veterinary care standards. Human contractions occur by consuming contaminated animal products or interacting with infected animals. Objective: This study aims to provide an updated understanding of brucellosis, from its epidemiology and pathogenesis to diagnosis and treatment strategies. It emphasizes the importance of ongoing research, knowledge exchange, and interdisciplinary collaboration for effective disease control and prevention, highlighting its global health implications. Methods: Pathogenesis involves intricate interactions between bacteria and the host immune system, resulting in chronic infections characterized by diverse clinical manifestations. The diagnostic process is arduous owing to non-specific symptomatology and sampling challenges, necessitating a fusion of clinical and laboratory evaluations, including blood cultures, serological assays, and molecular methods. Management typically entails multiple antibiotics, although the rise in antibiotic-resistant Brucella strains poses a problem. Animal vaccination is a potential strategy to curb the spread of infection, particularly within livestock populations. Results: The study provides insights into the complex pathogenesis of brucellosis, the challenges in its diagnosis, and the management strategies involving antibiotic therapy and animal vaccination. It also highlights the emerging issue of antibiotic-resistant Brucella strains. Conclusions: In conclusion, brucellosis is a significant zoonotic disease with implications for public health. Efforts should be directed towards improved diagnostic methods, antibiotic stewardship to combat antibiotic resistance, and developing and implementing effective animal vaccination programs. Interdisciplinary collaboration and ongoing research are crucial for addressing the global health implications of brucellosis.

          Related collections

          Most cited references164

          • Record: found
          • Abstract: found
          • Article: not found

          Human brucellosis.

          Human brucellosis still presents scientists and clinicians with several challenges, such as the understanding of pathogenic mechanisms of Brucella spp, the identification of markers for disease severity, progression, and treatment response, and the development of improved treatment regimens. Molecular studies have shed new light on the pathogenesis of Brucella spp, and new technologies have permitted the development of diagnostic tools that will be useful in developing countries, where brucellosis is still a very common but often neglected disease. However, further studies are needed to establish optimum treatment regimens and local and international control programmes. This Review summarises current knowledge of the pathogenic mechanisms, new diagnostic advances, therapeutic options, and the situation of developing countries in regard to human brucellosis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Factors That Influence the Immune Response to Vaccination

            SUMMARY There is substantial variation between individuals in the immune response to vaccination. In this review, we provide an overview of the plethora of studies that have investigated factors that influence humoral and cellular vaccine responses in humans. These include intrinsic host factors (such as age, sex, genetics, and comorbidities), perinatal factors (such as gestational age, birth weight, feeding method, and maternal factors), and extrinsic factors (such as preexisting immunity, microbiota, infections, and antibiotics). Further, environmental factors (such as geographic location, season, family size, and toxins), behavioral factors (such as smoking, alcohol consumption, exercise, and sleep), and nutritional factors (such as body mass index, micronutrients, and enteropathy) also influence how individuals respond to vaccines. Moreover, vaccine factors (such as vaccine type, product, adjuvant, and dose) and administration factors (schedule, site, route, time of vaccination, and coadministered vaccines and other drugs) are also important. An understanding of all these factors and their impacts in the design of vaccine studies and decisions on vaccination schedules offers ways to improve vaccine immunogenicity and efficacy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

              Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiological and pathological processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens. In addition to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel anti-obesity, anticancer and anti-infective drugs. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease. This article discusses the biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clinical trials.
                Bookmark

                Author and article information

                Journal
                Ann Med
                Ann Med
                Annals of Medicine
                Taylor & Francis
                0785-3890
                1365-2060
                2 January 2024
                2023
                2 January 2024
                : 55
                : 2
                : 2295398
                Affiliations
                [a ]Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University , Unaizah, Saudi Arabia
                [b ]Faculty of Medicine and Health Technology, Tampere University , Tampere, Finland
                [c ]Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard University , New Delhi, India
                [d ]Center for Microbiology and Phage Therapy, Biomedical Sciences, Zewail City of Science and Technology , Giza, Egypt
                [e ]Faculty of Applied Health Science, Galala University , Suez, Egypt
                [f ]Department of General Medicine, All India Institute of Medical Sciences , Bhopal, India
                [g ]Department of Biotechnology, Pondicherry University , Puducherry, India
                [h ]Department of Pharmacognosy, College of Pharmacy, King Khalid University (KKU) , Abha, Saudi Arabia
                [i ]Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University , Unaizah, Saudi Arabia
                [j ]Fimlab Ltd., Tampere University Hospital , Tampere, Finland
                Author notes
                Ashok Aspatwar ashok.aspatwar@ 123456tuni.fi Faculty of Medicine and Health Technology, Tampere University , Tampere 33520, Finland
                Author information
                https://orcid.org/0000-0002-3498-797X
                https://orcid.org/0000-0002-6938-7835
                Article
                2295398
                10.1080/07853890.2023.2295398
                10769134
                38165919
                49ad2135-82f5-429e-8d69-d443a2377bd3
                © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

                History
                Page count
                Figures: 0, Tables: 5, Pages: 24, Words: 16713
                Categories
                Review Article
                Infectious Diseases

                Medicine
                brucellosis,zoonotic disease,brucella,livestock and wildlife,public health threats,antibiotic-resistant strains

                Comments

                Comment on this article